Latest Earnings Analysis

• ARKO (ARKO) Q3 2024: 150 Store Dealerization to Add $8.5M Run-Rate, Refocusing Retail Footprint
  November 07, 2024 · ARKO
• CarGurus (CARG) Q3 2024: Marketplace Margin Expands 540bps as Dealer Spend Accelerates
  November 07, 2024 · CARG
• ARHS Q3 2024: Demand Comp Declines 11%, Showroom Expansion and Product Innovation Drive Long-Term Focus
  November 07, 2024 · ARHS
• Ardent Health (ARDT) Q3 2024: Margin Expands 60bps as Outpatient Growth and Cost Controls Accelerate
  November 07, 2024 · ARDT
• BlackLine (BL) Q3 2024: Strategic Portfolio Hits 31% of Sales as Enterprise Focus Drives Renewal Strength
  November 07, 2024 · BL
• Arcturus Therapeutics (ARCT) Q3 2024: $25M Milestone Secured as CoStave Commercialization Scales in Japan
  November 07, 2024 · ARCT
• CARS (CARS) Q3 2024: OEM Revenue Jumps 17% as Platform Strategy Drives Dealer Monetization
  November 07, 2024 · CARS
• Allogene Therapeutics (ALLO) Q3 2024: 50% Response Rate in RCC Cohort Signals Off-the-Shelf CAR-T Expansion
  November 07, 2024 · ALLO
• Albemarle (ALB) Q3 2024: CapEx Slashed by $800M as Cost Reset Targets 50% Cut
  November 07, 2024 · ALB
• ENACT (ACT) Q3 2024: Capital Return Climbs to $283M as Portfolio Quality Holds Amid Market Shifts
  November 07, 2024 · ACT
• ACRE Q3 2024: Risk-Rated Loan Exposure Down 33% as Portfolio Reshaping Accelerates
  November 07, 2024 · ACRE
• Akebia (AKBA) Q3 2024: Vafcio Contracts Secure 60% Dialysis Access Ahead of January Launch
  November 07, 2024 · AKBA
• Backblaze (BLZE) Q3 2024: $8M Cost Reset Fuels Sales Expansion and Margin Surge
  November 07, 2024 · BLZE
• Akamai (AKAM) Q3 2024: Security Run Rate Surges Past $2B as Compute Grows 28%
  November 07, 2024 · AKAM
• AKA Brands (AKA) Q3 2024: U.S. Sales Surge 19.5% as Omnichannel and Test-and-Repeat Model Drive Margin Highs
  November 07, 2024 · AKA
• ACV Auctions (ACVA) Q3 2024: Auction & Assurance Revenue Climbs 52%, Deepening Dealer Platform Penetration
  November 07, 2024 · ACVA
• Barrings BDC (BBDC) Q3 2024: Non-Accruals Drop to 0.5% as Portfolio Rotation Nears Completion
  November 07, 2024 · BBDC
• ADC Therapeutics (ADCT) Q3 2024: Zynlonta Revenue Rises 26% as Pipeline Focus Shifts to Hematology
  November 07, 2024 · ADCT
• ADEA (ADEA) Q3 2024: $200M Buyback Authorization Signals Capital Return Shift Amid 60% EBITDA Margin
  November 07, 2024 · ADEA
• ACMR Q3 2024: Single-Wafer Cleaning Hits 79% Mix, Tahoe Platform Expands Market Reach
  November 07, 2024 · ACMR
• ADMA (ADMA) Q3 2024: Ascentive Drives 78% Revenue Surge, Margin Expansion on Track for 2026
  November 07, 2024 · ADMA
• Adaptive Biotechnologies (ADPT) Q3 2024: MRD Revenue Jumps 52% as ASP and Pharma Momentum Accelerate
  November 07, 2024 · ADPT
• Excellus Technologies (ACLS) Q3 2024: Bookings Slide to $84M as China Digestion Signals Softer Start to 2025
  November 07, 2024 · ACLS
• ADTRAN (ADTN) Q3 2024: Free Cash Flow Jumps to $23M as Fiber Demand and Bookings Rebound
  November 07, 2024 · ADTN
• Advantage Solutions (ADV) Q3 2024: Experiential Services Jump 12% as Retailer Demand Shifts
  November 07, 2024 · ADV
• ACI Worldwide (ACIW) Q3 2024: Bank Segment Jumps 43% as Real-Time Payments Expand Global Reach
  November 07, 2024 · ACIW
• Agilon Health (AGL) Q3 2024: Exits 10% of Payer Contracts, Resets Margin Baseline for 2025
  November 07, 2024 · AGL
• Borr Drilling (BORR) Q3 2024: 10% Dayrate Uplift Locks In 2025 Revenue Visibility
  November 07, 2024 · BORR
• Achieve Life Sciences (ACHV) Q3 2024: $20M SVB Loan Refinancing Extends Runway for NDA Push
  November 07, 2024 · ACHV
• BARK (BARK) Q2 2025: Commerce Revenue Jumps 26% as Retail Expansion Outpaces DTC Transition
  November 07, 2024 · BARK
• Archer Aviation (ACHR) Q3 2024: $6B Order Book Signals Early Global Air Taxi Deployment
  November 07, 2024 · ACHR
• Air Products (APD) Q4 2024: EBITDA Margin Expands 460bps as Clean Hydrogen Strategy Scales
  November 07, 2024 · APD
• APA (APA) Q3 2024: North Sea Exit Triggers $571M Impairment, Reshaping Portfolio Focus
  November 07, 2024 · APA
• Artivion (AORT) Q3 2024: EBITDA Margin Expands 270bps as Global Portfolio Drives Double-Digit Growth
  November 07, 2024 · AORT
• Airbnb (ABNB) Q3 2024: Supply Growth Tops 10% as Expansion Markets Outpace Core
  November 07, 2024 · ABNB
• Arista Networks (ANET) Q3 2024: AI Center Pipeline Doubles to $1.5B, Reshaping Growth Mix
  November 07, 2024 · ANET
• AAON (AAON) Q3 2024: Data Center Backlog Surges 32%, Doubling Segment Capacity for 2025
  November 07, 2024 · AAON
• Amoresco (AMRC) Q3 2024: Contracted Backlog Surges 56%, Locking in $1.9B Project Visibility
  November 07, 2024 · AMRC
• Brilliant Earth (BRLT) Q3 2024: Gross Margin Expands 230bps as Fine Jewelry Drives Repeat Sales
  November 07, 2024 · BRLT
• Amplify Energy (AMPY) Q3 2024: Beta Well Success Unlocks Multi-Year Reserve Upside
  November 07, 2024 · AMPY
• Applied Optoelectronics (AAOI) Q3 2024: 260% CATV Ramp Signals New Growth Phase
  November 07, 2024 · AAOI
• Amprius Technologies (AMPX) Q3 2024: Product Revenue Surges 176% as Capacity Expansion Unlocks Customer Growth
  November 07, 2024 · AMPX
• AACG Q3 2024: Portfolio Training Drives 21% Enrollment Surge, Margin Pressure Mounts
  November 07, 2024 · AACG
• Amplitude (AMPL) Q3 2024: $8M ARR Expansion and 23% Multi-Product Adoption Signal Platform Consolidation Momentum
  November 07, 2024 · AMPL
• AMN Healthcare (AMN) Q3 2024: Nurse and Allied Revenue Down 30%, Margin Reset Signals Industry Inflection
  November 07, 2024 · AMN
• Amylx Pharmaceuticals (AMLX) Q3 2024: R&D Spend Drops 29% as Avexitide Phase III Readout Anchors Pipeline Focus
  November 07, 2024 · AMLX
• Axon (AXON) Q3 2024: Taser Segment Grows 36%, AI Era Bundle Sets Up Multi-Year Expansion
  November 07, 2024 · AXON
• Bentley Systems (BSY) Q3 2024: 15% FCF Growth Underscores Capital Allocation Discipline
  November 07, 2024 · BSY
• AudioEye (AEYE) Q3 2024: Partner Channel Hits 59% of Revenue as Accretive ADA Site Compliance Deal Expands Reach
  November 07, 2024 · AEYE
• B2Gold (BTG) Q3 2024: Goose Project Spend Hits C$165M as Production Pivot Intensifies
  November 07, 2024 · BTG